ID

23866

Description

Study part: Serious Adverse Event (SAE)- Additional/ Follow- Up Information Week 36/ Early Withdrawal Visit.A Phase 2 Multicenter, Double-blind, Placebo-controlled, Study to to Evaluate the Corticosteroid- sparing effects of Mepolizumab in Subjects with Hypereosinophilic Syndromes (HES) and Evaluate Efficacy and Safety of Mepolizumab in Controlling the Clinical Signs and Symptoms of subjects with HES Patient Level Data: Study Listed on ClinicalStudyDataRequest.com. Sponsor: GlaxoSmithKline. Study ID: 100185, Clinical Study ID:MHE100185.

Keywords

  1. 7/15/17 7/15/17 -
Copyright Holder

GlaxoSmithKline

Uploaded on

July 15, 2017

DOI

To request one please log in.

License

Creative Commons BY-NC 3.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Serious Adverse Event (SAE)- Additional/ Follow- Up Information Week 36 Mepolizumab HES NCT00086658

Serious Adverse Event (SAE)- Additional/ Follow- Up Information Week 36

Serious Adverse Event (SAE)- Additional/ Follow- Up Information
Description

Serious Adverse Event (SAE)- Additional/ Follow- Up Information

Alias
UMLS CUI-1
C1519255
Subject ID
Description

Subject ID

Data type

text

Alias
UMLS CUI [1]
C2348585
Centre Number
Description

Centre Number

Data type

integer

Alias
UMLS CUI [1,1]
C0600091
UMLS CUI [1,2]
C0019994
Randomisation Number
Description

Randomisation Number

Data type

integer

Alias
UMLS CUI [1,1]
C0034656
UMLS CUI [1,2]
C0237753
SECTION 12 SAE Additional/Follow-up Information
Description

SAE

Data type

text

Alias
UMLS CUI [1]
C1519255
Investigator’s signature
Description

Investigator signature

Data type

text

Alias
UMLS CUI [1]
C2346576
Investigator’s name
Description

Investigator name

Data type

text

Alias
UMLS CUI [1]
C2826892
Date
Description

Date

Data type

date

Alias
UMLS CUI [1]
C0011008

Similar models

Serious Adverse Event (SAE)- Additional/ Follow- Up Information Week 36

Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
Serious Adverse Event (SAE)- Additional/ Follow- Up Information
C1519255 (UMLS CUI-1)
Subject ID
Item
Subject ID
text
C2348585 (UMLS CUI [1])
Centre Number
Item
Centre Number
integer
C0600091 (UMLS CUI [1,1])
C0019994 (UMLS CUI [1,2])
Randomisation Number
Item
Randomisation Number
integer
C0034656 (UMLS CUI [1,1])
C0237753 (UMLS CUI [1,2])
SAE
Item
SECTION 12 SAE Additional/Follow-up Information
text
C1519255 (UMLS CUI [1])
Investigator signature
Item
Investigator’s signature
text
C2346576 (UMLS CUI [1])
Investigator name
Item
Investigator’s name
text
C2826892 (UMLS CUI [1])
Date
Item
Date
date
C0011008 (UMLS CUI [1])

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial